Pipeline embolisation device for the treatment of complex intracranial aneurysms (MTG10)
NICE has developed medical technology guidance on the Pipeline embolisation device.
NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The 'case for adoption' recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This 'case' is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.
NICE has said that the Pipeline embolisation device can be used to treat complex giant or large intracranial aneurysms which can’t be treated with surgery, and would otherwise be treated with another procedure known as stent-assisted coiling using a large number of coils. Hospital teams may want to use the Pipeline embolisation device because the evidence shows that it is effective and safe and can cost less in some situations.
- MTG10 Pipeline embolisation device for the treatment of complex intracranial aneurysms: guidance (web format)
This page was last updated: 04 July 2012
Information for the public
Implementation tools and resources
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.